GEN Exclusives

More »

GEN News Highlights

More »
Aug 6, 2009

Millipore Licenses iPS Cell-Production Method from BU

  • Boston University (BU) granted rights related to a method for creating induced pluripotent stem (iPS) cells to Millipore. The cells are derived from mouse fibroblasts by using a single virus vector instead of multiple viruses in the reprogramming process, according to BU.
    The vector has been licensed to Millipore for nonhuman research reagent use and is expected to be made commercially available later this year.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »